adenosine monophosphate has been researched along with ledipasvir in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batool, M; Choi, S; Haseeb, M; Kim, M; Pirzada, RH | 1 |
1 other study(ies) available for adenosine monophosphate and ledipasvir
| Article | Year |
|---|---|
Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Benzimidazoles; Chlorocebus aethiops; Fluorenes; Molecular Docking Simulation; SARS-CoV-2; Vero Cells; Virus Replication | 2021 |